Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease (Q42917851)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 24, 2010

Language	Label	Description	Also known as
English	Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease	scientific article published on July 24, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

0 references

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

6

object named as

Shan Mou

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20816602

6 July 2024

author name string

Beili Shi

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Zhaohui Ni

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Wenyan Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Zanzhe Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Leyi Gu

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Wei Fang

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Qin Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Liou Cao

9

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Yucheng Yan

10

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Jiaqi Qian

11

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20816602

6 July 2024

publication date

24 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S095362051000141X?httpAccept=text/xml

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

https://api.elsevier.com/content/article/PII:S095362051000141X?httpAccept=text/plain

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

European Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

444-448

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Epidemiology of cardiovascular disease in chronic renal disease

1

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study

2

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Cardiovascular disease in early stages of chronic kidney disease in a Chinese population

4

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.

6

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

7

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease

8

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy

9

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase

10

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

11

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation

12

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

14

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure

15

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Total nitric oxide production is low in patients with chronic renal disease

16

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease

18

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.

19

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

20

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients

21

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice

22

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?

23

1 reference

10.1016/J.EJIM.2010.07.001

https://api.crossref.org/works/10.1016/J.EJIM.2010.07.001

6 July 2024

Identifiers

10.1016/J.EJIM.2010.07.001

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42917851&oldid=2196975876"